...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Name Confusion

Why the F dont they just change the name to stop all this confusion?

It is one of the cheaper corporate fixes. Not only cant they sell or partner their companies, they cant even avoid confusion about their names, this group is beyond frustrating.

Maybe DM will address this on this on the CC - ha ha 

5
Dec 11, 2020 11:13PM

Dec 12, 2020 07:54AM
1
Dec 12, 2020 08:17AM
2
Dec 12, 2020 02:35PM

Dec 12, 2020 03:37PM
1
Dec 12, 2020 04:09PM
1
Dec 12, 2020 04:56PM
3
Dec 12, 2020 05:22PM
1
Dec 12, 2020 05:32PM
1
Dec 12, 2020 05:58PM

Dec 12, 2020 06:04PM
1
Dec 12, 2020 09:03PM

Dec 13, 2020 10:35AM
Share
New Message
Please login to post a reply